Patents by Inventor Zhonghua Dai

Zhonghua Dai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bladder cancer tumor marker, antibody and use thereof
    Patent number: 9073995
    Abstract: Provided in the present invention are an aberrantly glycosylated integrin, AG-?3?1, and use thereof as a bladder cancer marker. Also provided in the present invention are a hybridoma cell generating an anti-AG-?3?1 monoclonal antibody, a monoclonal antibody BCMab1 secreted by the same, and use of BCMab1 in the preparation of a medicament for the treatment of bladder cancer. Also provided in the present invention is use of inhibitors of GAL3ST2 and N-acetylgalactosaminyltransferase 1 in the preparation of a medicament for the treatment of bladder cancer.
    Type: Grant
    Filed: August 12, 2011
    Date of Patent: July 7, 2015
    Assignee: Institute of Biophysics, Chinese Academy of Sciences
    Inventors: Chong Li, Zusen Fan, Honglian Zhang, Zhonghua Dai, Haidong Tang, Jun Chen
  • Method and system for supplying emergency power to nuclear power plant
    Patent number: 8975781
    Abstract: Method and system for supplying emergency power to nuclear power plant, wherein the method includes, providing accumulator battery system, connected to emergency bus, the accumulator battery system is monitored by online monitoring system; in case of power loss of electrical devices of the nuclear power plant, the online monitoring system starts the accumulator battery system to provide power supply to the electrical devices of the nuclear power plant via the emergency bus. The present application is adapt to the key technologies and battery management technologies of million kilowatt-class advanced pressurized water reactor nuclear power plant, facilitating to improve the safety of the nuclear power plant in case of serious natural disasters beyond design working conditions.
    Type: Grant
    Filed: May 16, 2012
    Date of Patent: March 10, 2015
    Assignee: China Guangdong Nuclear Power Holding Corporation
    Inventors: Shanming Zhang, Changshen Lu, Zhonghua Dai, Junqi Chen, Chengming Wang, Yongnian Wang, Gang Zhu, Shuzhou Li, Jiedong Lin, Yukun Wu, Guangchao Su, Zongchuan Mei, Xuehua Han, Qiquan Zeng, Weigang Huang, Hongjiang Lin, Jun Li
  • METHOD AND SYSTEM FOR SUPPLYING EMERGENCY POWER TO NUCLEAR POWER PLANT
    Publication number: 20140001863
    Abstract: Method and system for supplying emergency power to nuclear power plant, wherein the method includes, providing accumulator battery system, connected to emergency bus, the accumulator battery system is monitored by online monitoring system; in case of power loss of electrical devices of the nuclear power plant, the online monitoring system starts the accumulator battery system to provide power supply to the electrical devices of the nuclear power plant via the emergency bus. The present application is adapt to the key technologies and battery management technologies of million kilowatt-class advanced pressurized water reactor nuclear power plant, facilitating to improve the safety of the nuclear power plant in case of serious natural disasters beyond design working conditions.
    Type: Application
    Filed: May 16, 2012
    Publication date: January 2, 2014
    Applicant: CHINA GUANGDONG NUCLEAR POWER HOLDING CORPORATION
    Inventors: Shanming Zhang, Changshen Lu, Zhonghua Dai, Junqi Chen, Chengming Wang, Yongnian Wang, Gang Zhu, Shuzhou Li, Jiedong Lin, Yukun Wu, Guangchao Su, Zongchuan Mei, Xuehua Han, Qiquan Zeng, Weigang Huang, Hongjiang Lin, Jun Li
  • BLADDER CANCER TUMOR MARKER, ANTIBODY AND USE THEREOF
    Publication number: 20130164216
    Abstract: Provided in the present invention are an aberrantly glycosylated integrin, AG-?3?1, and use thereof as a bladder cancer marker. Also provided in the present invention are a hybridoma cell generating an anti-AG-?3?1 monoclonal antibody, a monoclonal antibody BCMab1 secreted by the same, and use of BCMab1 in the preparation of a medicament for the treatment of bladder cancer. Also provided in the present invention is use of inhibitors of GAL3ST2 and N-acetylgalactosaminyltransferase 1 in the preparation of a medicament for the treatment of bladder cancer.
    Type: Application
    Filed: August 12, 2011
    Publication date: June 27, 2013
    Applicant: Institute Of Biophysics, Chinese Academy Of Sciences
    Inventors: Chong Li, Zusen Fan, Honglian Zhang, Zhonghua Dai, Haidong Tang, Jun Chen